What Is the First-Line Treatment for Erythroderma?
Initial management of erythroderma relies on a supportive framework common to all types of the condition. It targets skin barrier support, environmental temperature regulation, and relief of pruritus, with specific measures applied when secondary bacterial infection is clinically evident.
Treatment Approach
First-line care centres on supportive measures — including medication review, restoration of skin barrier function, and symptomatic management of pruritus — with additional antimicrobial considerations when secondary infection is present. The full regimen, clinical decision points, and complete algorithm are available in the protocol below.
Primary Clinical Goal
Relief of pruritus.
References
DOI: 10.1016/j.adengl.2018.05.033
- Treatment approach should include discontinuation of any unnecessary medications and appropriate workup to exclude an underlying malignancy.
- Regulating environmental temperature is crucial since patients with this condition loose homeostatic body functions that prevent cooling or overheating.
- Skin barrier function can be improved with colloid baths and wet compresses on not more than a quarter of the body at a time, along with emollient creams and low-potency topical corticosteroids.
- Oral, intramuscular or intravenous sedative antihistamines can alleviate scratching, thus preventing secondary skin infections while relieving pruritus and anxiety (eg, hydroxyzine hydrochloride, 25-50 mg P.O. QID).
- Individualize antimicrobial treatment if evident clinical signs of secondary bacterial infection (i.e. bleach baths and intranasal mupirocin in severe AD; cephalexin 250-500 mg QID in extensive impetigo lesions).
View source ↗